{"id":13664,"date":"2007-09-17T00:00:00","date_gmt":"2007-09-17T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/m004gmtg416\/"},"modified":"2019-03-01T15:04:28","modified_gmt":"2019-03-01T15:04:28","slug":"m004gmtg416","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg416\/","title":{"rendered":"CBI’s Annual Recalls Summit"},"content":{"rendered":"

Featured Conference<\/b> <\/p>\n

CBI’s Annual Recalls Summit<\/b>
Comprehensive Policies and Procedures for Ensuring Effective Recalls from Manufacturing to Wholesalers, End Users and Hospitals<\/i>
September 17 – 18, 2007 * Arlington, VA<\/b> <\/p>\n

For more information or to register, please visit the conference website<\/a>.<\/b> <\/p>\n<\/p>\n

CLASS I DRUG RECALLS ON THE RISE<\/b><\/p>\n

CDER performed 45 Class I recalls of human drugs deemed to have “very serious potential to cause harm, injury or death” in the last fiscal year [and]\u2026the period from Oct. 1, 2005, to Sept. 30, 2006, also saw 193 Class II recalls of drugs deemed “to have the potential to cause harm,” but where the damage is reversible, and 128 Class III recalls, which are generally for labeling violations and do not pose a direct health hazard
\u2013 FDA News Daily Bulletin<\/em><\/p>\n

Planning for, and navigating through, a product recall is an enormous concern for drug, device and biotech companies.\u00a0 Daily reports of potential recalls or market withdrawals for common prescription and OTC drugs flood the public domain, proving that even industry giants are subject to a recall.\u00a0<\/b> A product recall is potentially detrimental to a company\u2019s image causing lost opportunity costs as well as the direct costs from performing the actual recall.\u00a0 Ensuring that everyone, from management to marketing to customer service to quality and regulatory, is aware of the recall strategy is vital to a company\u2019s preparedness.\u00a0 This is the only conference that provides a platform for the industry to discuss critical topics.\u00a0 Industry leaders reconvene in 2007 to discuss:<\/p>\n